CORTEX PHARMACEUTICALS INC/DE/ 5
5 · CORTEX PHARMACEUTICALS INC/DE/ · Filed Feb 7, 2007
Insider Transaction Report
Form 5
ROGERS GARY ALLEN
Sr VP, Pharmaceutical Research
Transactions
- Award
Options to Purchase Common Stock
2002-12-16+5,000→ 5,000 total(indirect: By Spouse)Exercise: $0.75Exp: 2012-12-16→ Common Stock (5,000 underlying) - Award
Options to Purchase Common Stock
2000-09-05+3,399→ 3,399 total(indirect: By Spouse)Exercise: $3.00Exp: 2010-09-05→ Common Stock (3,399 underlying) - Award
Options to Purchase Common Stock
2003-12-09+10,000→ 10,000 total(indirect: By Spouse)Exercise: $2.76Exp: 2013-12-09→ Common Stock (10,000 underlying) - Award
Options to Purchase Common Stock
2005-12-01+15,000→ 15,000 total(indirect: By Spouse)Exercise: $2.35Exp: 2015-12-01→ Common Stock (15,000 underlying) - Award
Options to Purchase Common Stock
2006-12-18+15,000→ 15,000 total(indirect: By Spouse)Exercise: $1.30Exp: 2016-12-18→ Common Stock (15,000 underlying) - Award
Options to Purchase Common Stock
2004-12-16+10,000→ 10,000 total(indirect: By Spouse)Exercise: $2.68Exp: 2014-12-16→ Common Stock (10,000 underlying)
Footnotes (6)
- [F1]The option became fully vested and exercisable as of September 5, 2003.
- [F2]The option became fully vested and exercisable as of December 16, 2005.
- [F3]The option became fully vested and exercisable as of December 9, 2006.
- [F4]The option becomes vested and exercisable in three equal annual installments beginning on December 16, 2005.
- [F5]The option becomes vested and exerciable in three equal annual installments beginning on December 1, 2006.
- [F6]The option becomes vested and exercisable in three equal annual installments beginning on December 18, 2007.